 Connection
Jeffrey Olsen to Rectal Neoplasms
This is a "connection" page, showing publications Jeffrey Olsen has written about Rectal Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
4.430 |
|
|
|
-
Wojcieszynski AP, Chuong MD, Hawkins M, Jethwa KR, Kim H, Raldow A, Sanford NN, Olsen JR. Rectal Cancer Update: Which Treatment Effects Are the Least "Brutal"? Int J Radiat Oncol Biol Phys. 2024 Jan 01; 118(1):1-7.
Score: 0.854
-
Chuong MD, Anker CJ, Buckstein MH, Hawkins MA, Kharofa J, Raldow AC, Sanford NN, Wojcieszysnki A, Olsen JR. Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options. Int J Radiat Oncol Biol Phys. 2023 03 01; 115(3):545-552.
Score: 0.806
-
Avant A, Olsen JR. Optimizing Rectal Cancer Neoadjuvant Therapy-How to Manage a cCR? Int J Radiat Oncol Biol Phys. 2020 03 15; 106(4):669-670.
Score: 0.656
-
Jabbour SK, Apisarnthanarax S, Hallemeier CL, Huguet F, Murphy JD, Olsen JR. GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):749-758.
Score: 0.582
-
Markovina S, Youssef F, Roy A, Aggarwal S, Khwaja S, DeWees T, Tan B, Hunt S, Myerson RJ, Chang DT, Parikh PJ, Olsen JR. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis. Int J Radiat Oncol Biol Phys. 2017 10 01; 99(2):417-426.
Score: 0.541
-
Moyer AM, Vogel JD, Lai SH, Kim H, Chin RI, Moskalenko M, Olsen JR, Birnbaum EH, Silviera ML, Mutch MG, Chapman BC. Total Neoadjuvant Therapy in Rectal Cancer: Multi-center Comparison of Induction Chemotherapy and Long-Course Chemoradiation Versus Short-Course Radiation and Consolidative Chemotherapy. J Gastrointest Surg. 2023 05; 27(5):980-989.
Score: 0.201
-
Chapman BC, Lai SH, Friedrich T, Lieu CH, Moskalenko M, Olsen JR, Herter W, Birnbaum EH, McCarter MD, Vogel JD. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy. Dis Colon Rectum. 2023 04 01; 66(4):521-530.
Score: 0.186
-
Kim H, Pedersen K, Olsen JR, Mutch MG, Chin RI, Glasgow SC, Wise PE, Silviera ML, Tan BR, Wang-Gillam A, Lim KH, Suresh R, Amin M, Huang Y, Henke LE, Park H, Ciorba MA, Badiyan S, Parikh PJ, Roach MC, Hunt SR. Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial. Clin Colorectal Cancer. 2021 09; 20(3):e185-e193.
Score: 0.177
-
Hallemeier CL, Huguet F, Tait D, Buckstein MH, Anker CJ, Kharofa J, Olsen JR, Jabbour SK. Randomized Trials for Esophageal, Liver, Pancreas, and Rectal Cancers. Int J Radiat Oncol Biol Phys. 2021 02 01; 109(2):305-311.
Score: 0.174
-
Roy A, Mahasittiwat P, Weiner AA, Hunt SR, Mutch MG, Birnbaum EH, Kodner IJ, Read TE, Fleshman JW, Olsen JR, Myerson RJ, Parikh PJ. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e51-e58.
Score: 0.128
-
Khwaja SS, Roy A, Markovina S, Dewees TA, Hunt S, Tan B, Myerson RJ, Olsen JR, Parikh PJ. Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer. Int J Radiat Oncol Biol Phys. 2016 08 01; 95(5):1429-1438.
Score: 0.125
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|